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Abstract: 48 
Muscle dysfunction is a common feature of severe sepsis and multi-organ failure. Recent 49 
evidence implicates bioenergetic dysfunction and oxidative damage as important underlying 50 
pathophysiological mechanisms. Increased abundance of uncoupling protein-3 (UCP-3) in 51 
sepsis suggests increased mitochondrial proton leak, which may reduce mitochondrial 52 
coupling efficiency but limit ROS production. Using a murine model, we examined metabolic, 53 
cardiovascular and skeletal muscle contractile changes following induction of peritoneal 54 
sepsis in wild-type and Ucp3(-/-) mice. Mitochondrial membrane potential (Δψm) was 55 
measured using two-photon microscopy in living diaphragm, and contractile function was 56 
measured in diaphragm muscle strips. The kinetic relationship between membrane potential 57 
and oxygen consumption was determined using a modular kinetic approach in isolated 58 
mitochondria. Sepsis was associated with significant whole body metabolic suppression, 59 
hypothermia and cardiovascular dysfunction. Maximal force generation was reduced and 60 
fatigue accelerated in ex vivo diaphragm muscle strips from septic mice. Mitochondrial 61 
membrane potential was lower in the isolated diaphragm from septic mice despite normal 62 
substrate oxidation kinetics and proton leak in skeletal muscle mitochondria. Even though 63 
wild-type mice exhibited an absolute 26 ± 6% higher UCP-3 protein abundance at 24 hours, 64 
no differences were seen in whole animal or diaphragm physiology, nor in survival rates, 65 
between wild-type and Ucp3(-/-) mice. In conclusion, this murine sepsis model shows a 66 
hypometabolic phenotype with evidence of significant cardiovascular and muscle 67 
dysfunction. This was associated with lower Δψm and alterations in mitochondrial ATP 68 
turnover and phosphorylation pathway. However, UCP-3 does not play an important 69 
functional role, despite its upregulation. (246 words)   70 
Keywords: Sepsis, Mitochondria, Metabolism, Uncoupling protein 3, Skeletal 71 
muscle 72 
73 
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Glossary 74 
i/p  Intraperitoneal 75 
Δψm   Mitochondrial membrane potential 76 
RER  Respiratory exchange ratio 77 
s/c Subcutaneous 78 
SDS Sodium dodecyl sulfate 79 
TMRM  Tetramethylrhodamine methyl ester 80 
TPMP  Methyltriphenylphosphonium 81 
UCP  Uncoupling protein 82 
VO2  Whole body oxygen consumption 83 
VCO2  Whole body carbon dioxide production 84 
WT  Wild-type 85 
 86 
87 
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Introduction  88 
Muscle dysfunction is a common feature of severe sepsis and other critical illnesses, 89 
and a major cause of both prolonged intensive care stay (21) and long-term disability (7, 34). 90 
Neuropathic and myopathic features are well recognized (7, 38, 40, 50), yet the underlying 91 
pathophysiology remains incompletely understood. A net catabolic state, impaired cellular 92 
and calcium signalling, bioenergetic dysfunction and oxidative damage are all implicated (30, 93 
33, 50). In both patients and animal models, sepsis is associated with decreased skeletal 94 
muscle mitochondrial respiratory capacity, reduced mitochondrial protein levels and 95 
increased rates of generation of reactive oxygen and nitrogen species (ROS and RNS) (12, 13, 96 
16, 18, 20, 26), all of which may impair muscle function.  97 
The proton electrochemical gradient created by activity of the mitochondrial 98 
respiratory chain generates a transmembrane potential (Δψm) that is used by the FoF1 ATP 99 
synthase to phosphorylate ADP to ATP (coupled respiration). However, a variable proportion 100 
of protons are uncoupled from ATP synthesis by leaking back into the mitochondrial matrix, 101 
the rate of proton flux being dependent upon the magnitude of Δψm. Proton leak rate is 102 
variable and considered to constitute ~20% of the basal metabolic rate of hepatocytes, and 103 
up to 50% in rat skeletal muscle (53). Uncoupled respiration has basal and inducible 104 
components (35), with the inducible part forming the mechanism of heat generation in 105 
brown adipose tissue through uncoupling protein (UCP)-1 (44). Other uncoupling proteins – 106 
UCP-2-5 – have been identified but their physiologic role and biochemical mechanisms 107 
remain controversial. One suggestion is that following activation by ROS and by-products of 108 
ROS damage, these UCPs may induce a mitochondrial proton leak (11, 25) that, in turn, may 109 
down-regulate ROS production, forming a negative feedback loop (42).  110 
Processes interfering with maintenance of Δψm may impact on cellular energy supply 111 
and mitochondrial ROS production (23, 45). Sepsis is associated with high levels of nitric 112 
oxide production which impairs respiratory enzyme function (12, 27). Increased expression 113 
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of UCP-2 and UCP-3, reported in septic mouse models (60, 66), suggests a possible increase 114 
in proton leak with a reduction in mitochondrial coupling efficiency (the proportion of 115 
mitochondrial oxygen consumption used to drive ATP synthesis). A consequential decrease in 116 
mitochondrial ATP production could have significant impact on muscle contractile function.  117 
The traditional approach of measuring whole body oxygen consumption as a marker 118 
of metabolic rate in sepsis does not take into account the proportion of oxygen use that is 119 
uncoupled from oxidative phophorylation. This proportion may fluctuate considerably over 120 
time, particularly in view of the significant thermoregulatory and inflammatory disturbances 121 
that occur in this condition.  122 
The aim of our study was to determine changes in metabolism, muscle function and 123 
the influence of UCP3 in an established rodent model of sepsis. We hypothesised that sepsis 124 
leads to metabolic suppression and muscle dysfunction as a result of decreased capacity of 125 
mitochondrial ATP synthesis, and that UCP3, an uncoupling protein restricted to muscle and 126 
adipose tissue, offers protection to ROS-induced muscle contractile dysfunction at the 127 
expense of mitochondrial efficiency.  128 
 129 
130 
7 
 
Methods 131 
Mouse septic model. All experiments were performed under the UK Animals (Scientific 132 
Procedures) Act 1986 with approval from the University College London Ethics Committee. 133 
Ten-week old male C57 black mice were purchased from Charles River (Margate, UK) and 134 
maintained in the university animal facility until they reached 25-35 weeks of age. They were 135 
housed in cages (maximum 6 per cage) with standard bedding, environment-enhancing 136 
objects and free access to water and chow diet. Cages were maintained at room 137 
temperature with 12-hour light and dark cycles. Comparison was made against age-matched 138 
litter mice from three Ucp3(-/-) homozygote breeding pairs (originally produced by Gong et al 139 
(29) and back-crossed ten generations with wild-type C57 mice). Confirmatory genotyping 140 
was carried out using tail snips. All Ucp3(-/-) mice were kept in individually ventilated cages 141 
with litter-mates of the same sex kept in the same cage after weaning. Mice were allowed to 142 
acclimatize to the laboratory for one week prior to the start of experiments. 143 
The model of sepsis has been described in detail elsewhere (67). In summary, sepsis 144 
was induced by intraperitoneal injection of diluted cecal slurry (20 ml/kg) under a brief 145 
period of isoflurane anesthesia. Sham mice received 20 ml/kg of 0.9% saline i/p. As septic 146 
mice stop eating, a further sham starved group was added to account for this potential 147 
confounding factor. Starvation commenced after i/p injection of saline. Mice were block-148 
randomized to each treatment group for each set of experiments. 149 
All mice received 0.9% saline 10ml/kg s/c at time 0 h, and 50 ml/kg of 5% 150 
dextrose/0.81% saline solution at 6, 18, 30 and 42 h. Initial experiments observed 72-hour 151 
survival, serum biochemical markers of organ failure, blood gases and echocardiography 152 
(Vivid 7, GE Healthcare, Chalfont St. Giles, Bucks, UK) at 24 hours. Clinical variables 153 
comprising behaviour, appearance temperature and acidemia were used to score sepsis 154 
severity (67). Severity scoring was carried out by two observers, one of whom was blinded to 155 
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the randomization process. The scores given by the two observers were consistently equal. 156 
Subsequent studies are outlined below.  157 
Whole animal metabolism. Whole body metabolic rate of sham and septic mice were 158 
measured for 24h in individual metabolic chambers (Oxymax, Columbus Instruments, 159 
Columbus, OH). Gas samples from each box were sampled for 90 seconds at 8-minute 160 
intervals. Oxygen consumption (VO2) and CO2 production (VCO2) were calculated using 161 
standard formulae. The respiratory exchange ratio (RER) was calculated as the ratio of VCO2 162 
to VO2. Values near 1 indicate a predominance of carbohydrate metabolism while values 163 
approaching 0.7 indicate fatty acid oxidation (36). Rectal temperature was measured at 0, 6, 164 
18 and 24h, and animals were weighed at 0 and 24h time-points.  165 
Assessment of cardiac function: Echocardiography was performed at 0, 6 and 24h in sham 166 
and septic wild-type and Ucp3(-/-) mice using a 14 MHz probe connected to a Vivid 7 167 
Dimension device as previously described (67). Aortic blood flow velocity was measured in 168 
the proximal ascending aorta immediately before the bifurcation of the right carotid artery 169 
using pulse-wave Doppler. Stroke volume was calculated by multiplying the velocity time 170 
integral (VTI) from six consecutive cycles (equivalent to one respiratory cycle) by aortic cross-171 
sectional area (using an aortic diameter of 0.26 cm). Average peak-to-peak distance and 172 
maximum velocity over six consecutive systolic cycles were used to measure heart rate and 173 
peak velocity, the latter being a marker of left ventricular contractility (12). Cardiac output 174 
was calculated as the product of stroke volume and heart rate. 175 
Western blotting for UCP3 protein. UCP-3 protein abundance was measured in snap-frozen 176 
heart and skeletal muscle tissue at 10 and 24h following induction of sepsis in the wild-type 177 
mice. After SDS protein precipitation, 10 µg protein was separated on a 12% SDS 178 
polyacrylamide gel and transferred to nitrocellulose. Membranes were probed overnight at 179 
4˚C with the primary antibody (Rabbit anti-UCP3: PA1-055 Pierce antibodies, ThermoFisher 180 
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Scientific, Loughborough, Leics, UK) at 1:1000 dilutions in blocking buffer. Each sample was 181 
loaded twice in the same gel, and each gel repeated once. Following incubation with 182 
secondary antibody (goat-anti-rabbit antibody: DAKO, Ely, Cambs, UK), cross-reacted 183 
proteins were visualised by enhanced chemiluminescence (Amersham Biosciences, Little 184 
Chalfont, Bucks, UK). Densitometry measurements were made using Image J image 185 
processing and National Institute of Health analysis software. A single control sample was 186 
used in each gel and all results normalized to this control allowing comparison between 187 
samples in different gels. Alpha-tubulin (1:5000 dilution, Abcam 7291, Cambridge, Cambs, 188 
UK) was used to ensure equal loading of gels and transfer of proteins from gel to membrane. 189 
Each membrane was also Coomassie stained to ensure equal loading and transfer. 190 
Diaphragm preparation. At 24h, under terminal isoflurane anesthesia, a midline laparotomy 191 
was performed and the diaphragm excised en-bloc (still attached to ribs laterally) and pinned 192 
(taut without excess stretch) at its edges in a petri dish filled with physiological saline 193 
(containing of mmol/L: Na+ 145, K+ 5, Ca2+ 5, Mg2+ 1, HCO3- 25, Cl- 118, SO42- 1, PO43- 1, 194 
glucose 10, pyruvate 10, and equilibrated with 95% O2 and 5% CO2 (pH 7.4). Tubocurarine 195 
(2.5 μm) was added to stop spontaneous neuromuscular junction activity. Diaphragm strips 196 
(~1 mm wide) were dissected using stereomicroscopy; a strip consisted of muscle fibers with 197 
the ribs at one end and central tendon at the other. Strips were allowed to rest in 198 
physiological saline for at least 30 minutes prior to experimentation. All experiments were 199 
performed within 5h of tissue harvest. 200 
Force and power measurements. Aluminium foil T-clips were attached to the rib and central 201 
tendon at the ends of the diaphragm strips using cyanoacrylate gel glue. The muscle strips 202 
were transferred to a temperature-controlled (23°C) Perspex bath through which 203 
physiological saline was continuously circulated. At one end the strip was attached to a 204 
combined motor and force transducer (Model 300B, Cambridge Technology, Inc., 205 
Watertown, MA, USA) and the other end to a hook mounted onto a micrometer allowing 206 
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alteration of resting muscle length. Electrical stimulation (MultiStim System-D330, Digitimer, 207 
Welwyn Garden City, Herts, UK) was delivered by two platinum electrodes placed in the bath 208 
just above and below the belly of the muscle fibres. A program written in TestPoint (Keithley 209 
Instruments, Bracknell, Berks, UK) controlled stimulation and motor arm position and 210 
recorded force, length and stimulation.  A DAS-1800AO Series A/D board (Keithley 211 
Instruments) was used. The computer program could be altered to achieve complex 212 
protocols such as force recording during repeated phased cyclical tetanic stimulations while 213 
making controlled changes to muscle length.  214 
 Following system calibration and zeroing, optimal stimulation voltage (at 96Hz) was 215 
found for the muscle strip; these stimulus parameters were used throughout the 216 
experiment.  The length/tension relationship was explored by increasing the muscle length in 217 
0.2-0.4 mm increments to identify L0, the muscle length at which filament overlap was 218 
optimal for isometric tetanic force development.  A single 350 ms tetanic stimulation was 219 
used to measure the maximal achievable tetanic isometric force. The maximum force 220 
generated was expressed relative to muscle cross-sectional area (CSA) to take account 221 
muscle size.    222 
CSA  = 4.9 x d x M /L0 223 
where 4.9 is the wet-to-dry ratio (65), d is density (assumed to be 1 mg/mm3), M is dry mass 224 
of the muscle and L0 is muscle length as defined above. M and L0 were measured at the end 225 
of the experiment.  226 
The ability of the muscle to produce work and power was measured using a pattern 227 
of sinusoidal movement and stimulation that mimics diaphragm muscle action in vivo. This 228 
pattern was described and optimized by Stevens and Faulkner for diaphragm muscle strips 229 
from C57 black mice (59). The amplitude of the length change was ±0.4mm. Stimulation was 230 
applied for ~30% of each movement cycle and was approximately centered on the time at 231 
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which the muscle length was longest. The maximum power was measured in one cycle of 232 
movement at frequency 4Hz. The initial muscle strip length was incrementally increased to 233 
find optimal range. To measure the effects of fatigue on power, cycles of length change with 234 
stimulation were repeated over a one-minute period. The frequency of movement was 2 Hz, 235 
which is equivalent to 120 breaths/min, close to the average respiratory rate measured in 236 
septic mice.  237 
The net work performed by the muscle strip is the ‘positive work’ performed during 238 
muscle shortening and contraction, minus the ‘negative work’ to bring the muscle back to its 239 
original length (59). We evaluated net work as follows: Passive force was recorded during 240 
movement without electrical stimulation, and then during the same movement with 241 
electrical stimulation. The unstimulated record was subtracted from the stimulated record to 242 
give the active force value. Net work performed during the movement cycle was evaluated 243 
as the area circumscribed by the active force vs. length change graph, referred to as work 244 
loop (Fig. 5C). The average power output during the movement cycle was calculated by 245 
dividing net work by cycle duration, and is expressed relative to the muscle strip wet weight 246 
to take account of size.  247 
Diaphragm muscle mitochondrial membrane potential (Δψm). Diaphragm muscle strips (3-4 248 
mm wide) taken at 24h from paired fed sham and septic wild-type mice were pinned onto a 249 
Sylgard™ imaging chamber and continuously superfused with oxygenated saline solution at 250 
23°C on the stage of an upright epifluorescent microscope (Zeiss Axioskop, Carl Zeiss, 251 
Cambridge, Cambs, UK) with a x63 Achroplan water dipping objective and 0.9 numerical 252 
aperture. The strips were incubated for 45 min with the lipophilic cationic dye, 253 
tetramethylrhodamine methyl ester (TMRM) (Invitrogen, Paisley, Renfrewshire, UK) added to 254 
the circulating saline solution at low concentration (100 nM). Fluorophore excitation was 255 
achieved using a femtosecond pulsed Ti;sapphire tunable multiphoton laser (Coherent 256 
Chameleon, Santa Clara, CA) set at wavelength 720nm. A photomultiplier tube detected the 257 
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emitted light, which was first split by a long pass 510nm dichroic mirror before passing 258 
through a band pass filter 560-615nm.  259 
 Accumulation of TMRM in cells and mitochondria depends on both plasma 260 
membrane potential and Δψm. At low loading concentrations, TMRM fluorescence intensity 261 
is linear to its concentration (24). The baseline fluorescence intensity of TMRM in muscle 262 
strips isolated from sham and septic mice was measured and directly compared. 263 
Fluorescence intensity was also determined in the presence of the ATP synthase inhibitor, 264 
oligomycin (10 µg/ml, Sigma-Aldrich, Gillingham, Dorset, UK) and the protonophore, 265 
carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP) (1µM, Sigma-Aldrich). The 266 
addition of oligomycin can differentiate states where mitochondria are depolarized as a 267 
result of high ATP production and flux through the respiratory chain, from other states 268 
where a pathological process has resulted in ATP synthase to switch back to its native ATPase 269 
activity (17, 28). The addition of FCCP results in dissipation of Δψm, confirming that the 270 
TMRM signal is truly mitochondrial and unquenched. 271 
 Stepped z-stacked images (10 at 4µm apart) were taken in all three states (baseline, 272 
after oligomycin, after FCCP) and assimilated to form a single projection for measurement of 273 
TMRM fluorescence intensity. Three different fields of muscle cells corresponding to the 274 
brightest regions of the muscle strip with at least 5 cells per field were analyzed using Zeiss 275 
LSM software, and values from the three fields averaged to give a single result per specimen. 276 
As it was unclear how Δψm would vary between subjects and in sepsis, eight subjects per 277 
group were arbitrarily chosen. Statistical comparison was made within the group (i.e. sham 278 
or septic) using ANOVA with repeated measures, and between groups using Student’s t-test 279 
for each state (baseline, +oligomycin, +FCCP).  280 
 281 
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Isolation of mitochondria from total skeletal muscle. At the 24h time-point, lower limb, 282 
back and respiratory skeletal muscle were taken from wild-type fed sham, starved sham and 283 
septic mice, with clinical severity scoring performed beforehand. Mitochondria were then 284 
isolated as described by Bhattacharya et al (8) at 4°C. In brief, muscles were rapidly removed, 285 
weighed and placed in ice-cold isolation solution (KCl 100mM, Tris/HCl 50mM, EGTA 2mM, 286 
pH 7.4 at 4°C). The muscle was minced and the muscle slurry washed and protease-digested 287 
in digestion buffer (KCl 100mM, Tris/HCl 50mM, EGTA 2mM, ATP 1mM, MgCl2.6H2O 5mM, 288 
Defatted Bovine Serum Albumin 0.5%, Protease Type VIII [(245.7units/100ml, Sigma P 289 
5380)], pH 7.4). The mixture was Dounce homogenized and spun for 10 min at 490g. 290 
Supernatant was filtered and spun in 2-3 stages for 10 min each at 10,400g. The final pellet 291 
(mitochondria) was resuspended in a small volume of isolation medium (0.6-0.8 ml) and 292 
protein concentration measured using a BCA protein assay kit (ThermoFisher Scientific). 293 
To determine percentage recovery of mitochondria from skeletal muscle homogenate from 294 
all three groups of mice, citrate synthase activity was assayed at each step of the isolation 295 
process by spectrophotometric determination of oxaloacetate-dependent coenzyme A-296 
coupled reduction of DTNB at 412nm (57), in an assay adapted for 96-well plates. 297 
Respiratory activity of isolated mitochondria and modular kinetic analysis. Respiratory 298 
activity of isolated mitochondria was determined using a Clark electrode chamber (Rank 299 
Brothers, Bottisham, Cambs, UK) surrounded by a thermostatically-controlled water jacket at 300 
30°C and calibrated with air-saturated assay medium. Mitochondria (0.35mg/ml) were 301 
incubated in assay medium (KCl 120mM, KH2PO4 5mM, HEPES 3mM, EGTA 1mM, 0.3% (w/v) 302 
de-fatted BSA, pH 7.4).  303 
 Respiratory control ratios were calculated as state 3 respiratory rate after addition of 304 
ADP (200μM) divided by the state 4 rate after ADP phosphorylation with pyruvate 5mM and 305 
malate 2.5mM as substrates. Ratios of 3-10 have been quoted as acceptable RCR ratios (51, 306 
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58). FCCP (1-3μM) was added at end-study to measure maximal oxygen consumption rate; a 307 
three-fold rise in respiratory rate has been used to indicate good mitochondrial quality (58). 308 
Modular kinetic analysis. This technique allows interrogation of mitochondrial pathways 309 
that generate Δψm (substrate oxidation), and pathways that utilize/dissipate it (proton leak 310 
and ATP turnover) (10, 15, 47, 48). The conceptual division of mitochondrial respiration into 311 
these three kinetic modules is further detailed in Figure 1. The modules are divided into a 312 
substrate oxidation module (Δψm producing); an ATP turnover module, comprising 313 
phosphorylation and associated transport activity (Δψm dissipating); and a proton leak 314 
module (Δψm dissipating). Substrate oxidation and proton leak kinetics are determined 315 
directly, while ATP turnover is derived by subtracting proton leak from total Δψm –dissipating 316 
pathway activity. Studies were performed in a specially adapted 7 ml Clark electrode 317 
chamber that simultaneously measures oxygen consumption and Δψm using a 318 
methyltriphenylphosphonium (TPMP+) electrode in the presence of nigericin (0.1μM) to 319 
abolish the pH gradient. Following addition of mitochondria (0.35 mg/ml) to the assay 320 
medium (KCl 120mM, KH2PO4 5mM, HEPES 3mM, EGTA 1mM, 0.3% (w/v) de-fatted BSA, 321 
Nigericin 0.1 μM; pH 7.4), the TPMP+ electrode was calibrated with five sequential 0.5 μM 322 
additions of TPMP. Mitochondria were energized with succinate 8mM (plus rotenone 5 μM). 323 
The starting oxygen level and the zero point were used for two-point calibration of the Clark 324 
electrode (100% and 0% points). FCCP was added at the end of all experimental runs to 325 
correct for any drift of the TPMP+ electrode. Due to the large number of mitochondria 326 
needed for each of the protocols, mitochondria isolated from two mice in the same group 327 
were pooled. Each protocol was run twice and the results averaged. 328 
 Since the kinetic response of each module to an effector reflects a change in the 329 
common intermediate, Δψm, the kinetic curves of modules that consume protonmotive force 330 
are independent of the respiratory substrate used to generate that Δψm (2).  Succinate (8 331 
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mM) was used as a substrate in all experiments, since mitochondrial energization is more 332 
readily achieved than with NADH-linked substrates (41). The kinetic dependency of oxygen 333 
consumption towards Δψm was described for each kinetic pathway module by modulating 334 
Δψm using effectors targeted towards another module within the system. Substrate 335 
oxidation kinetics were measured in the presence of oligomycin (1.3 μM) by sequential 336 
depolarization with FCCP (0.2-1 μM). Proton leak kinetics were determined in the presence 337 
of oligomycin 1.3 μM by sequential additions of malonate (0.1–2.3 mM). The kinetics of total 338 
Δψm-dissipating activity (proton leak + ATP turnover reactions) were measured under state 3 339 
conditions (ADP 2 mM) by sequential additions of malonate (0.1–2.3 mM). ATP turnover 340 
kinetics (phosphorylation and transport reactions) were subsequently calculated by 341 
subtraction of proton leak rate from the state 3 respiratory rate at the corresponding value 342 
of Δψm. FCCP (1 μM) was added at the end of all experimental runs to correct for drift of the 343 
TPMP+ electrode.  344 
 To test for statistical significance, respiration rates between flanking values of Δψm 345 
were interpolated so that for each curve, oxygen consumption at Δψm of -170mV was 346 
calculated. This value was the highest Δψm common to all conditions. The higher the value of 347 
Δψm, the higher the flux of protons through the various Δψm-consuming modules, and 348 
therefore the more likely to see a result emerging through the inherent noise of the 349 
experimental setup. Additionally, uncoupling proteins (UCP3 in particular) may require a high 350 
Δψm to become active (48). One-way ANOVA was used to test for difference in VO2 between 351 
the groups at Δψm of -170mV.  352 
Statistical analysis  353 
Statistical analysis was performed using SPSS 18.0 (IBM) software. Data were normally 354 
distributed, unless stated. Student’s t-test, Mann-Whitney U tests, and analysis of variance 355 
(ANOVA) (with and without repeated measures calculations) were used to test for statistical 356 
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significance with the alpha error set to <5% (p<0.05). Tukey and Dunnet post hoc tests were 357 
used to define significance.  358 
 359 
Results 360 
Whole body physiology and skeletal muscle function 361 
Mortality and whole-animal metabolism. Mortality rates of the septic wild-type (n=11) and 362 
Ucp3(-/-) mice (n=12) at 24h, 48h and 72h time-points were similar, at approximately 20%, 363 
70% and 73%, respectively (Figure 2). No deaths occurred in either WT (n=10) or Ucp3(-/-) 364 
(n=9) sham groups. Septic mice developed a mixed respiratory and metabolic acidosis with 365 
biochemical evidence of acute kidney and liver injury (Table 1). The degree of organ 366 
dysfunction and acidosis correlated with severity of illness and mortality.   367 
  Sepsis produced a large and rapid drop in core temperature and metabolic rate with 368 
good correlation between temperature and VO2 (R2=0.95) [Fig. 3A-C]. Responses were similar 369 
in both wild-type and Ucp3(-/-) groups. In both genotypes, the sham fed mice lost a small 370 
amount of weight over the first 24 hours (-2 ± 1% SEM body weight change; p=0.08). This was 371 
more pronounced in the starved sham mice (-8 ± 1% SEM body weight change; p<0.0001). 372 
However, the septic mice gained weight (5 ± 1% SEM body weight; p<0.001), due to a 373 
combination of renal dysfunction and fluid sequestration in body cavities (pleural effusions 374 
and ascites) and subcutaneous tissues evident at postmortem examination (Fig 3D).  375 
Cardiac function. Echocardiography was performed in 16 sham and 13 severe septic wild-376 
type mice, and nine sham and seven severe septic Ucp3(-/-) mice (Figure 4). Compared to 377 
baseline values, there was a marked reduction in cardiac output at 6 and 24 h in the severe 378 
septic mice in both genotypes (p<0.02 within group ANOVA, but no statistical significance 379 
between the two genotypes). Decreases were noted in left ventricular contractility 380 
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(measured as peak flow velocity), stroke volume and heart rate. No difference was seen 381 
between wild-type and Ucp3(-/-) groups. 382 
Diaphragm muscle force and power. Measurements were made on diaphragm strips from 383 
both wild-type (9 fed sham, 8 starved sham, 9 septic wild-type) and Ucp3(-/-) (6 fed sham, 8 384 
starved sham, 7 septic) mice. The average ages (±SEM) were 35±2 weeks for wild-type mice 385 
and 35±3.5 weeks for Ucp3(-/-) mice (p=0.92), with average weights of 32±4 and 34±3 g, 386 
respectively (p=0.048). At 24h, maximal tetanic isometric force generated by diaphragm 387 
strips from septic wild-type mice was 28% lower than that produced by either fed or starved 388 
sham mice (p<0.05) (Fig. 5A). Similarly, maximal power generated during a single length cycle 389 
at 4 Hz (mimicking 240 breaths/min, typical for normal mice) was 36% and 28% lower in 390 
muscle strips from septic mice than from fed and starved sham mice, respectively (p<0.05 391 
one-way ANOVA) (Fig. 5B). Similar results were seen in the muscle strips from Ucp3(-/-) 392 
animals (Figure 5A and B). The work loop profiles generated by all sets of muscle strips 393 
showed a similar contraction-relaxation profile (Fig. 5C). 394 
  The effect of fatigue on power output was assessed during cycles of movement and 395 
stimulation repeated for one minute. A movement frequency of 2 Hz was used to mimic the 396 
respiratory rate of 120 breaths/min in a septic mouse.  A characteristic pattern of power 397 
fatigue was seen: an initial rapid decline was followed by a plateau phase, and then a second 398 
rapid decline to a lower plateau (Fig. 5D).  The initial power in the fatigue test (Fig. 5D) was 399 
about half of the maximum power (shown in Fig. 5B) due to the difference in movement 400 
frequency, 2 and 4 Hz respectively. For both genotypes, the power output throughout the 401 
fatigue test was lower in the septic group than in either of the sham groups. For both 402 
genotypes, the duration of the first plateau ended sooner in the septic group (35 ± 3 cycles) 403 
compared to both fed sham (41 ± 6 cycles) and starved sham (41 ± 4 cycles) strips (p= 0.02). 404 
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  In summary, sepsis resulted in severe hypothermia and metabolic suppression 405 
associated with cardiovascular dysfunction, lower muscle force and power generation, and 406 
earlier fatigue. As no differences were seen between wild-type and Ucp3(-/-)mice, this implies 407 
that UCP3 does not affect the response to sepsis neither at the level of the whole animal nor 408 
at the level of muscle (dys)function. Further experiments were thus performed using only 409 
wild-type animals. 410 
Mitochondrial physiology 411 
A detailed analysis of mitochondrial function was performed to determine whether 412 
mitochondrial dysfunction, potentially including increased proton leak, could underlie the 413 
muscle dysfunction described above. Studies were performed using wild-type mice only.  414 
UCP protein abundance. UCP3 protein expression in diaphragms taken from wild-type sham 415 
(n=6) and severe septic mice (n=9) at 24h was assessed by Western blot. UCP3 protein 416 
abundance increased by 26±6% (SEM) compared to sham (p<0.05). The α-tubulin 417 
densitometry signal decreased in septic wild-type mouse diaphragms by 22±7% at 10h 418 
[p=0.016], and by 12 ± 6% at 24h [NS]. The ratio of UCP3 to α-tubulin change was 47 ± 13% 419 
(p<0.05; Figure 6). Coomassie staining confirmed equal protein loading and transfer. UCP2 420 
was not detectable in these samples using 3 different commercially available antibodies. 421 
Mitochondrial membrane potential in diaphragm muscle strips. .Muscle strips from nine fed 422 
sham and nine septic wild-type mice were compared simultaneously. TMRM loading took 45 423 
minutes to reach steady state prior to imaging. A typical double row and subsarcolemmal 424 
high intensity fluorescence pattern was observed in all muscle cells, representing 425 
interfibrillar and subsarcolemmal groups of mitochondria (Figures 7A-C). Baseline TMRM 426 
fluorescence in diaphragms from wild-type septic mice was significantly lower than 427 
diaphragms from sham mice, suggesting a decrease in mitochondrial membrane potential 428 
(Δψm) (Figure 7D). The ATP synthase inhibitor, oligomycin was then added to observe 429 
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changes in Δψm following inhibition of mitochondrial ATP production. This differentiates 430 
between states where mitochondria are depolarized as a result of high ATP production and 431 
flux through the respiratory chain, from other states where the ATP synthase switches into 432 
its native ATPase activity (17, 28). In the diaphragm strips, oligomycin increased TMRM 433 
fluorescence, with a greater relative increase above baseline in the septic group (increase of 434 
30 ± 5% in septic diaphragm vs 16 ± 8% in sham; p<0.001). Absolute values of fluorescence 435 
post-oligomycin were not statistically different between the two groups (p=0.1), suggesting 436 
the differences are attributable to a difference in proton flux through the FoF1-ATPsynthase. 437 
The addition of FCCP resulted in complete dissipation of Δψm in all specimens examined, 438 
confirming unquenched mitochondrial TMRM signal (24).  439 
Citrate synthase activity and respiratory control of isolated mitochondria from skeletal 440 
muscle. Mitochondria were isolated from muscles of 8 fed sham, 8 starved sham and 13 441 
severe septic wild-type mice (clinical severity 5-6). Fractional recovery (mean ± SD) of citrate 442 
synthase activity at each step of the mitochondrial preparation process compared to the 443 
initial muscle homogenate was similar in all three groups, with a final recovery in the 444 
mitochondrial pellet of 43 ± 11% (fed sham), 38 ± 23% (starved sham) and 41 ± 9% (septic) 445 
(p=0.48). The respiratory control of the final mitochondrial pellet measured using the NADH-446 
linked substrates pyruvate and malate was also similar (3.0 ± 0.6 fed sham, 3.5 ± 0.9 starved 447 
sham, 2.9 ± 0.5 septic; p=0.47). 448 
Modular kinetic analysis of isolated skeletal muscle mitochondria. The effect of sepsis on 449 
the kinetic behavior of processes that govern Δψm were examined using modular kinetic 450 
analysis in 8 fed sham, 8 starved sham and 13 severe septic mice. Substrate oxidation (Δψm 451 
producing) and proton leak kinetics (Δψm consuming) were determined directly, while ATP 452 
turnover (Δψm consuming) was derived by subtracting proton leak from total Δψm–453 
dissipating pathway activity. Proton leak kinetics were similar in all three groups (Figs 8 A,B). 454 
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However, the kinetic behavior of total Δψm-dissipating processes  (Figs 8 C,D) and ATP 455 
turnover processes (Figs 8 E,F) were significantly affected in the septic mice: for a given 456 
membrane potential (-170 mV), the oxygen consumption rate was significantly lower in 457 
mitochondria from septic animals (207 ± 26 fed sham, 157 ± 53 starved sham, 120 ± 30 septic 458 
nmol oxygen/min/mg; p<0.05). While the substrate oxidation kinetic curves of the septic and 459 
fed sham mice were similar (Figs 8 G,H), the curve for the starved sham group (316 ± 19 nmol 460 
oxygen/min/mg) was significantly different compared to both fed sham (230 ± 17) and septic 461 
(312 ± 22) groups; p<0.05), with oxygen consumption rates lower at all values of Δψm.  462 
 463 
Discussion 464 
In this rodent model of sepsis and multi-organ failure, we have shown early muscle 465 
dysfunction and fatigue associated with metabolic suppression, lower mitochondrial 466 
membrane potential and phosphorylation capacity, but no change in mitochondrial proton 467 
leak despite an increase in UCP3 protein abundance. These changes were unaffected by 468 
presence or absence of UCP3 protein.  469 
 The pathophysiology of multi-organ failure and muscle dysfunction in established 470 
sepsis is complex and multifactorial. Recent interest has focused on bioenergetic 471 
dysfunction: increased production of reactive oxygen species results in disruption of 472 
metabolic processes and cell damage (12, 13, 61), while decreased transcription of 473 
mitochondrial proteins affects respiratory capacity (18, 32). A decrease in cell metabolism 474 
may also occur for other reasons, e.g. secondary to a decrease in thyroid activity associated 475 
with critical illness (9). 476 
  Recent publications have highlighted limitations of mouse models of sepsis and the 477 
lack of translation of successful treatments from animal models to humans (31, 56). Indeed, 478 
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significant disparity was reported between mice and humans in their gene expression profile 479 
response to inflammatory conditions including sepsis (56). We reported marked differences 480 
in the metabolic response to sepsis between rats and mice (67). As seen in the present study, 481 
mice showed an early and severity-dependent hypometabolic, hypothermic phenotype with 482 
early myocardial depression. This presentation is seen in approximately 10% of cases of 483 
human sepsis, and is associated with a 2-3 fold increased risk of mortality (4, 19). However, 484 
the ability to define the roles of specific genes by genetic manipulation and to study fully 485 
intact biological systems in complex diseases justify an ongoing role for rodent models in 486 
defining pathophysiological mechanisms (46). We did make considerable efforts to refine 487 
and optimize our murine septic model. These included using older mice equivalent to 30-40 488 
year old humans (63), injecting a standardized septic inoculum, providing regular fluid 489 
administration to limit hypovolemia-induced tissue hypoperfusion, and performing a block 490 
randomization for group allocation in experiments (67).  491 
 Metabolic suppression and hypothermia are well-described phenomena in septic mice, 492 
and are influenced by age, septic insult and ambient temperature (22, 54, 62, 67). We 493 
previously demonstrated that rewarming of septic mice to normothermia failed to increase 494 
metabolic rate (67), implying a primary metabolic suppression rather than a reactive 495 
response to hypothermia. 496 
 UCP3 is upregulated in sepsis (60, 66), prompting speculation about the role of this 497 
protein in decreasing mitochondrial coupling efficiency. This may however act as a negative 498 
feedback loop to reduce ROS production (11). We set out to establish the importance and 499 
functional consequence of this increase in UCP3 expression, but instead report no detectable 500 
differences in the responses of Ucp3(-/-) mice to sepsis. Rather than detecting effects on 501 
mitochondrial proton leak, our findings suggest that processes related to mitochondrial 502 
phosphorylation may be affected.  503 
22 
 
  Previous studies in healthy Ucp3(-/-) mice also found little difference in 504 
thermoregulation and oxygen consumption rate compared to their wild-type controls (6, 64). 505 
Despite a 5-fold increase in skeletal muscle UCP3 in mice given intraperitoneal endotoxin, Yu 506 
et al in fact described a drop in core temperature to 30°C (66). While we too observed an 507 
increase in skeletal muscle UCP3, we found no impact of the lack of UCP-3 protein upon 508 
metabolic changes, temperature, cardiovascular and muscle function, or mortality in sepsis. 509 
Similarly, while skeletal muscle mitochondria isolated from healthy Ucp3(-/-) mice showed 510 
more coupled respiration and increased ROS production (64), we could find no differences in 511 
force, power and response to repeated stimulation between diaphragm muscle strips 512 
isolated from septic wild-type and Ucp3(-/-) mice. The original description of the Ucp3(-/-) 513 
mouse showed no compensatory up-regulation of other UCPs (64), although it is conceivable 514 
that such up-regulation may be seen with sepsis. In line with previous work, we were unable 515 
to detect UCP2 in muscle from either sham or septic mice using a number of commercially 516 
available UCP2 antibodies (data not shown).   517 
  We imposed repeated work-loop cycles to mimic in vivo diaphragm muscle activity to 518 
assess muscle fatigue (59). To our knowledge, the present study is the first description of this 519 
functional assessment in a septic model. The plots show a characteristic three-phase 520 
response (39); the second phase, a quasi-plateau phase of reduced function, involves 521 
recruitment of oxidative metabolism and ends with depletion of high-energy substrates and 522 
accumulation of phosphate and other end-products of metabolism (5). We found that this 523 
second phase was significantly shorter in septic mice, was affected by hypoxia (data not 524 
shown) but was independent of UCP-3 protein expression. This finding supports the notion 525 
of linkage between disorders of oxidative metabolism and an inability to maintain high levels 526 
of energy substrate. 527 
  A significantly lower Δψm was seen in the diaphragmatic myocytes of septic mice. 528 
While previously shown in cells (1, 55), to our knowledge this is the first demonstration of 529 
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altered mitochondrial membrane potential in sepsis in a complex muscle preparation. The 530 
low Δψm was a consistent finding in the septic mice, and suggests either a decreased rate of 531 
Δψm generation (e.g. due to a respiratory chain defect) or an increase in turnover of 532 
pathways that dissipate the gradient such as proton leak or ATP production (23). Blocking 533 
ATP synthase with oligomycin increased fluorescence and hence Δψm. This rise was 534 
significant in the septic group and suggests higher ATP turnover in these diaphragm muscle 535 
cells. This was an unexpected finding as previous studies had shown lower respiratory 536 
complex activity and lower oxygen consumption in tissues and cells taken from septic 537 
animals and humans (13, 16, 20).  538 
  Our interrogation of kinetic pathways involved in the maintenance of Δψm implies 539 
that the mitochondrial pathway that generates Δψm through succinate oxidation was 540 
unaffected in this model of sepsis. Substrate oxidation rates of mitochondria isolated from 541 
starved sham mice were depressed at all values of Δψm compared to the other groups. This 542 
implies either an altered sensitivity of these mitochondria to FCCP and/or that metabolic 543 
adaptations in sepsis do not simply reflect a stressed nutritional state. Previous descriptions 544 
of mitochondrial function in sepsis suggest Complex I dysfunction (12, 13). While a full kinetic 545 
description of NADH-linked substrate oxidation kinetics was not attempted here due to 546 
technical constraints, neither state 3 nor state 4 respiration were significantly different 547 
between groups when the mitochondria were energized with complex 1 substrates pyruvate 548 
and malate. 549 
  Proton leak kinetics were unaffected by the septic insult, despite the rise in UCP3 550 
protein levels in the septic mice, although these experiments were not repeated in the 551 
presence of free fatty acids or GDP (47). However, ATP turnover kinetics were significantly 552 
affected in the septic mice with lower oxygen consumption rates at given values of Δψm 553 
when mitochondria were phosphorylating ADP. Defects in ATP synthase in sepsis have been 554 
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described previously and may explain these observations (16, 37, 43, 52). The higher ATP 555 
turnover in the diaphragms of septic mice suggested by the Δψm experiments, in conjunction 556 
with the altered ATP turnover kinetics seen in muscle mitochondria isolated from septic mice 557 
may explain, at least in part, the earlier fatigue observed in the diaphragm muscle strip 558 
studies.  559 
  An issue to consider with the use of isolated mitochondria, especially in conditions 560 
such as sepsis, is that removal from their usual cellular environment takes away the impact 561 
of local regulatory processes and high levels of inflammatory mediators, and also exposes 562 
them to a supranormal oxygen milieu. Such regulatory processes include energy-consuming 563 
pathways, resulting in altered ATP demand, or pathways that impose control over substrate 564 
trafficking into the mitochondria and substrate oxidation, thereby regulating respiratory 565 
chain function and, ultimately, ATP synthesis (14). Nitric oxide, pyruvate dehydrogenase 566 
kinase-4 (PDK4) and hypoxia inducible factor-1α (HIF-1α) are all implicated in sepsis (3, 12, 567 
49); these likely continue to impose control over mitochondrial function in the intact cell and 568 
tissues. Following mitochondrial isolation and washing, and exposure to hyperoxic 569 
conditions, such control may be lost. A comparison of our findings using in situ and isolated 570 
mitochondria implies that sepsis modifies both local regulatory processes and the oxidative 571 
phosphorylation machinery itself. These functional changes were not associated with 572 
swollen or ruptured mitochondria in an examination of electron micrographs of diaphragm 573 
muscles from a limited number of sham and septic mice (data not shown). Although, no 574 
formal morphological examination of these were carried out, no gross changes in the shape, 575 
size or distribution of mitochondria were noted.  576 
  In summary, the long-term, resuscitated septic mouse model that we have described 577 
exhibits metabolic suppression, hypothermia and decreased cardiovascular activity. 578 
Diaphragm muscle strips from septic mice exhibit increased fatiguability ex vivo; this may be 579 
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related in part to mitochondrial dysfunction. Despite increased UCP3 protein abundance in 580 
sepsis, kinetic analysis of isolated mitochondria from skeletal muscle revealed that proton 581 
leak kinetics were not different from sham controls, while the lack of UCP3 protein did not 582 
impact on mortality, physiological changes or muscle functionality. However, ATP turnover 583 
kinetics were significantly altered, implying a defect with ATP synthesis at the level of the 584 
FoF1 synthase or an associated transport process.  585 
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Figure legends 819 
Figure 1 Simplified illustration of mitochondrial bioenergetic pathways split into three groups 820 
of reactions: 1) reactions that generate Δψm (substrate kinetics), 2) reactions consuming Δψm 821 
to generate ATP (phosphorylation kinetics), and 3) reactions that consume Δψm without 822 
generating ATP (leak kinetics). Adapted from Nicholls & Ferguson 2002. 823 
 824 
Figure 2 Survival curve of wild-type (n=11) and UCP3(-/-) mice (n=12) after i/p injection of 825 
fecal slurry. Sham mice (10 wild-type, 9 UCP3(-/-)) received i/p saline. All animals received s/c 826 
fluids at 0, 6, 18, 30 and 42 hour time-points.  827 
 828 
Figure 3 Temperature (A) and oxygen consumption (B) of wild-type and UCP3(-/-) mice 829 
following induction of sepsis (or sham controls). (C) Plot of oxygen consumption against core 830 
temperature of wild-type and UCP3(-/-) mice. Line of best fit and correlation coefficient are 831 
noted on the graph. (D) Percentage weight change of sham and septic mice over 24 hours. 832 
Statistical significance (p<0.05) was seen between groups in each genotype. All mice received 833 
s/c fluid at 0, 6 and 18h time-points; food was withdrawn from starved sham mice 834 
immediately after i/p injection of saline.  835 
* p<0.05 compared to fed sham using two-way ANOVA for temperature data over time, and 836 
one-way ANOVA for weight data. 837 
 838 
 839 
Figure 4 Echocardiography results of wild-type and Ucp3(-/-) mice following i/p injection of 840 
fecal slurry or n-saline. All septic mice were in the severe category according to the clinical 841 
scoring scale. Results are mean ± SEM. *p<0.02 comparing sham values between the two 842 
genotypes; § p<0.01 comparing septic and sham values in same genotype using two-way 843 
ANOVA repeated measures. 844 
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 845 
Figure 5 (A) Maximal isometric force generated by 350ms tetanic stimulation in diaphragm 846 
strips taken from wild-type and Ucp3(-/-) mice and normalized to cross-sectional area. (B) 847 
Power generated by the muscle strips during sinusoidal length change at 4Hz with phasic 848 
tetanic stimulation simulating in vivo muscle function.  Power is expressed relative to muscle 849 
wet weight. (C) Example of a work-loop generated by muscle strips from WT fed sham, 850 
starved sham and septic mice (optimal muscle lengths: 8.4mm, 9.5mm, 9.7mm; muscle dry 851 
weight: 0.665mg, 0.627mg, 0.578mg, respectively). (D) Power performance of diaphragm 852 
strips taken from fed sham and septic wild-type and Ucp3(-/-) mice undertaking 120 repeated 853 
work-loop cycles at 2Hz over a 1 minute period. Values are the average power per cycle; for 854 
clarity some values are not shown.  The initial rapid decline is shallower, and the first plateau 855 
ends earlier (marked by broken vertical line), in the septic groups in both genotypes 856 
compared to the sham group.  Values are mean ± 1 SEM. 857 
 858 
Figure 6 Representative Western blots of UCP-3 protein content of diaphragm muscles from 859 
sham (n=6) and septic wild-type mice 24 h after injection of fecal slurry (n=8). B Mean (±SD) 860 
densitometry values of UCP-3 protein abundance at 10 h and 24 h in diaphragm muscle. 861 
Values were normalized to alpha-tubulin content. * p<0.05 compared to sham using one-way 862 
ANOVA. 863 
 864 
Figure 7 Live-cell images of TMRM (A) and Mitotracker green (B&C) fluorescence pattern in 865 
diaphragm muscle cells. Two distinct mitochondrial subpopulation of subsarcolemmal (SS) 866 
and intefibrillar (IF) are seen. Characteristic double band pattern of interfibrillar 867 
mitochondria is shown in B (arrowed). (C) Z-stack 3-D image projection of a diaphragm strip 868 
loaded with Mitotracker Green showing muscle and pleural cells on the surface. (D) Average 869 
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TMRM fluorescence intensity of isolated diaphragms strips from sham and septic wild-type 870 
mice at 24h bathed in TMRM 100nM (baseline), and after addition of oligomycin 5 μg/ml. 871 
(*p=0.016 independent sample t-test; § p<0.01 paired sample t-test comparing oligomycin to 872 
baseline fluorescence in the septic group). 873 
 874 
Figure 8 Dependency of oxygen consumption rate on Δψm for different Δψm–producing and -875 
dissipating kinetic modules (left panels), with oxygen consumption rates at Δψm of -170mV 876 
(right panels), for mitochondria isolated from total skeletal muscle of septic, fed sham and 877 
fasted sham mice. A & B, proton leak kinetics; C & D, total Δψm–dissipating pathways (proton 878 
leak + ATP turnover reactions) under state 3 conditions; E & F; ATP turnover kinetics 879 
(phosphorylation + transport reactions) – kinetic curves derived from subtraction of A from 880 
C; G & H, substrate (succinate) oxidation kinetics. 881 
*p<0.05 one-way ANOVA significance of septic vs. both sham groups; ** p<0.05 one-way 882 
ANOVA starved sham vs. fed sham and septic groups.  883 
 884 
 885 
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Table 1 Blood gas and serum biochemistry at 24 hours in wild-type mice following 887 
induction of sepsis with comparison against sham controls.  888 
 pH pCO2 
kPa 
pO2 
kPa 
Lactate 
mmol/l 
Hb 
g/dl 
Glucose 
mmol/L 
Urea 
mmol/l 
Creatinine 
μmol/l 
AST 
IU/l 
ALT 
IU/l 
Sham 7.33 ± 0.03 
4.3 ± 
0.3 
13.4 ± 
4.2 
2.4 ± 0.9 13.2 ± 
0.2 
11.7 ± 4.0 6.5 ± 2.0 10 ± 6 61 ± 
30 
24 ± 
14 
Septic 6.96 ± 
0.12* 
8.5 ± 
4.1* 
12.2 ± 
4.3 
5.0 ± 
1.2* 
15.1 ± 
1.6* 
14.9 ± 
2.4* 
34 ± 28* 30±15* 266 ± 
95* 
77 ± 
28* 
(mean ± SD *p<0.05) 889 
Hb Hemoglobin, AST Aspartate transaminase, ALT Alanine aminotransferase, IU international unit. 890 
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